| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
RESPIRATORY INFECTION |
1 Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford Radcliffe NHS Trust, Oxford OX3 7LJ, UK
2 Department of Paediatrics, Weatherall Institute of Molecular Medicine, Oxford Radcliffe NHS Trust, Oxford OX3 9DU, UK
3 Windeyer Institute of Medical Sciences, Royal Free and University College Medical School, University College London, London, UK
Correspondence to:
Correspondence to:
Dr R J O Davies, Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford Radcliffe NHS Trust, Oxford OX3 7LJ, UK;
robert.davies{at}ndm.ox.ac.uk
Background: The opportunistic fungus Pneumocystis jiroveci is a common cause of respiratory infection in immunocompromised patients. By contrast, pneumocystis pneumonia (PCP) occurs only rarely in immunocompetent individuals. Asymptomatic colonisation with P jiroveci has recently been described in patients who are either minimally immunosuppressed or who have underlying lung disorders such as bronchiectasis. We sought to determine the prevalence of asymptomatic colonisation by P jiroveci in a cohort of adult patients undergoing diagnostic bronchoscopy.
Methods: A prospective observational cohort study was performed in patients who required bronchoscopy and bronchoalveolar lavage (BAL) as part of their routine clinical assessment. All the samples underwent standard microbiological analysis and a Grocott methenamine silver stain was performed where clinically indicated to detect the presence of P jiroveci. Polymerase chain reaction for detection of P jiroveci specific DNA was also performed.
Results: Ninety three consecutive BAL fluid samples were analysed, 17 (18%) of which contained P jiroveci DNA. Of the potential predictors examined, only glucocorticoid use was significantly associated with detectable P jiroveci DNA. Eighteen patients were receiving oral glucocorticoids (equivalent to >20 mg/day prednisolone) at the time of bronchoscopy, of whom eight (44%) had detectable P jiroveci DNA. In contrast, P jiroveci was detected in only nine of 75 patients (12%) who were not receiving glucocorticoids (difference between proportions 32%, 95% CI 8 to 57; p=0.004, two tailed Fisher’s exact test).
Conclusions: P jiroveci colonisation, as determined by detection of P jiroveci DNA in BAL fluid, is common in HIV negative patients with primary respiratory disorders undergoing bronchoscopy and BAL. The higher prevalence in patients receiving corticosteroids suggests that oral glucocorticoid therapy is an independent risk factor for colonisation. In contrast, underlying lung cancer or COPD did not appear to be risk factors.
Keywords: Pneumocystis jiroveci; corticosteroids; bronchoalveolar lavage; immunosuppression
This article has been cited by other articles:
|
|
 |
|
  J L Davis, D A Welsh, C B Beard, J L Jones, G G Lawrence, M R Fox, K Crothers, A Morris, D Charbonnet, A Swartzman, et al. Pneumocystis colonisation is common among hospitalised HIV infected patients with non-Pneumocystis pneumonia Thorax, April 1, 2008; 63(4): 329 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Schmoldt, R. Schuhegger, T. Wendler, I. Huber, H. Sollner, M. Hogardt, H. Arbogast, J. Heesemann, L. Bader, and A. Sing Molecular Evidence of Nosocomial Pneumocystis jirovecii Transmission among 16 Patients after Kidney Transplantation J. Clin. Microbiol., March 1, 2008; 46(3): 966 - 971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J F Huggett, M S Taylor, G Kocjan, H E Evans, S Morris-Jones, V Gant, T Novak, A M Costello, A Zumla, and R F Miller Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients Thorax, February 1, 2008; 63(2): 154 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Uemura, K. Makimura, M. Onozaki, Y. Otsuka, Y. Shibuya, H. Yazaki, Y. Kikuchi, S. Abe, and S. Kudoh Development of a loop-mediated isothermal amplification method for diagnosing Pneumocystis pneumonia J. Med. Microbiol., January 1, 2008; 57(1): 50 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tasaka, N. Hasegawa, S. Kobayashi, W. Yamada, T. Nishimura, T. Takeuchi, and A. Ishizaka Serum Indicators for the Diagnosis of Pneumocystis Pneumonia Chest, April 1, 2007; 131(4): 1173 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Freeman, J. Davis, V. L. Anderson, W. Barson, D. N. Darnell, J. M. Puck, and S. M. Holland Pneumocystis jiroveci Infection in Patients With Hyper-Immunoglobulin E Syndrome Pediatrics, October 1, 2006; 118(4): e1271 - e1275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. M. Linssen, J. A. Jacobs, P. Beckers, K. E. Templeton, J. Bakkers, E. J. Kuijper, W. J. G. Melchers, M. Drent, and C. Vink Inter-laboratory comparison of three different real-time PCR assays for the detection of Pneumocystis jiroveci in bronchoalveolar lavage fluid samples. J. Med. Microbiol., September 1, 2006; 55(Pt 9): 1229 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Agarwal The Acronym "PCP" is Pneumocystis Pneumonia, Not Pneumocystis carinii Pneumonia Am. J. Roentgenol., December 1, 2005; 185(6): 1653 - 1654. [Full Text] [PDF]
|
|
|
|
|
|
R F Miller, A R Lindley, A Copas, H E Ambrose, R J O Davies, and A E Wakefield Genotypic variation in Pneumocystis jirovecii isolates in Britain Thorax, August 1, 2005; 60(8): 679 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Miller and L Huang Pneumocystis jirovecii infection Thorax, September 1, 2004; 59(9): 731 - 733. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Morris, F. C. Sciurba, I. P. Lebedeva, A. Githaiga, W. M. Elliott, J. C. Hogg, L. Huang, and K. A. Norris Association of Chronic Obstructive Pulmonary Disease Severity and Pneumocystis Colonization Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 408 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Flori, B. Bellete, F. Durand, H. Raberin, C. Cazorla, J. Hafid, F. Lucht, and R. T. M. Sung Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens J. Med. Microbiol., July 1, 2004; 53(7): 603 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Miller, R J Boyton, D M Mitchell, and O M Kan Pneumocystis pneumonia in humans is caused by P jiroveci not P carinii Thorax, January 1, 2004; 59(1): 83 - 84. [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Miller, A. R. Lindley, H. E. Ambrose, A. S. Malin, and A. E. Wakefield Genotypes of Pneumocystis jiroveci Isolates Obtained in Harare, Zimbabwe, and London, United Kingdom Antimicrob. Agents Chemother., December 1, 2003; 47(12): 3979 - 3981. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
